Sledovat
Kirsty Rhodes
Kirsty Rhodes
E-mailová adresa ověřena na: astrazeneca.com
Název
Citace
Citace
Rok
The epidemiology of multimorbidity in primary care: a retrospective cohort study
A Cassell, D Edwards, A Harshfield, K Rhodes, J Brimicombe, R Payne, ...
British Journal of General Practice 68 (669), e245-e251, 2018
4842018
Predictive distributions were developed for the extent of heterogeneity in meta-analyses of continuous outcome data
KM Rhodes, RM Turner, JPT Higgins
Journal of clinical epidemiology 68 (1), 52-60, 2015
3422015
Association of comorbidity and health service usage among patients with dementia in the UK: a population-based study
J Browne, DA Edwards, KM Rhodes, DJ Brimicombe, RA Payne
BMJ open 7 (3), e012546, 2017
1582017
Two new methods to fit models for network meta-analysis with random inconsistency effects
M Law, D Jackson, R Turner, K Rhodes, W Viechtbauer
BMC medical research methodology 16, 1-14, 2016
532016
Empirical evidence about inconsistency among studies in a pair-wise meta-analysis
KM Rhodes, RM Turner, JPT Higgins
Research Synthesis Methods, 2015
502015
Methods for calculating confidence and credible intervals for the residual between-study variance in random effects meta-regression models
D Jackson, R Turner, K Rhodes, W Viechtbauer
BMC Medical Research Methodology 14, 1-12, 2014
462014
Implementing informative priors for heterogeneity in meta‐analysis using meta‐regression and pseudo data
KM Rhodes, RM Turner, IR White, D Jackson, DJ Spiegelhalter, J Higgins
Statistics in Medicine 35 (29), 5495-5511, 2016
432016
De‐escalation treatment protocols for human papillomavirus‐associated oropharyngeal squamous cell carcinoma
L Masterson, D Moualed, A Masood, RC Dwivedi, R Benson, JC Sterling, ...
Cochrane Database of Systematic Reviews, 2014
412014
Between-trial heterogeneity in meta-analyses may be partially explained by reported design characteristics
KM Rhodes, RM Turner, J Savović, HE Jones, D Mawdsley, JPT Higgins
Journal of clinical epidemiology 95, 45-54, 2018
392018
Incorporating external evidence on between‐trial heterogeneity in network meta‐analysis
RM Turner, CP Domínguez‐Islas, D Jackson, KM Rhodes, IR White
Statistics in medicine 38 (8), 1321-1335, 2019
242019
Alternative weighting schemes when performing matching‐adjusted indirect comparisons
D Jackson, K Rhodes, M Ouwens
Research Synthesis Methods 12 (3), 333-346, 2021
222021
Population-adjusted indirect treatment comparison of the SOLO1 and PAOLA-1/ENGOT-ov25 trials evaluating maintenance olaparib or bevacizumab or the combination of both in newly …
I Vergote, I Ray-Coquard, DM Anderson, G Cantuaria, N Colombo, ...
European Journal of Cancer 157, 415-423, 2021
202021
Correlation between early endpoints and overall survival in non-small-cell lung cancer: A trial-level meta-analysis
K Shameer, Y Zhang, D Jackson, K Rhodes, IKA Neelufer, S Nampally, ...
Frontiers in Oncology 11, 672916, 2021
202021
Population adjusted indirect comparison of the SOLO1 and PAOLA-1/ENGOT-ov25 studies of olaparib with or without bevacizumab, bev alone and placebo in the maintenance treatment …
IB Vergote, KN Moore, R Hettle, K Rhodes, M Ouwens, I Ray-Coquard
Gynecologic Oncology 159, 19-20, 2020
182020
Adjusting trial results for biases in meta-analysis: combining data-based evidence on bias with detailed trial assessment
KM Rhodes, J Savović, R Elbers, HE Jones, JPT Higgins, JAC Sterne, ...
Journal of the Royal Statistical Society Series A: Statistics in Society 183 …, 2020
142020
EXAcerbations of COPD and their OutcomeS on CardioVascular diseases (EXACOS-CV) Programme: protocol of multicountry observational cohort studies
C Nordon, K Rhodes, JK Quint, CF Vogelmeier, SO Simons, NM Hawkins, ...
BMJ open 13 (4), e070022, 2023
112023
Label‐invariant models for the analysis of meta‐epidemiological data
KM Rhodes, D Mawdsley, RM Turner, HE Jones, J Savović, JPT Higgins
Statistics in medicine 37 (1), 60-70, 2018
92018
Financial incentives improve recognition but not treatment of cardiovascular risk factors in severe mental illness
CL Wilson, KM Rhodes, RA Payne
PloS one 12 (6), e0179392, 2017
82017
Relationship between risk, cumulative burden of exacerbations and mortality in patients with COPD: modelling analysis using data from the ETHOS study
K Rhodes, M Jenkins, E de Nigris, M Aurivillius, M Ouwens
BMC Medical Research Methodology 22 (1), 150, 2022
72022
Increased risk of severe cardiovascular events following exacerbations of COPD: a multi-database cohort study
C Vogelmeier, S Simons, E Garbe, D Sin, N Hawkins, N Manito, S Santos, ...
European Respiratory Journal 62 (suppl 67), 2023
62023
Systém momentálně nemůže danou operaci provést. Zkuste to znovu později.
Články 1–20